Overview
Whether you are preparing for the CBNC Nuclear Cardiology Board Exams or want to stay current on board-focused updates in nuclear cardiology, the ASNC Nuclear Cardiology Board Exam Prep Course is right for you. Based on the CBNC exam blueprint, esteemed Board Prep faculty teach via 19 pre-recorded presentations and will walk through the answer explanations to the 170 practice questions and much more.
Nuclear Cardiology Board Prep OnDemand includes:
- 2 years of access (through September 15, 2026) to the recorded virtual-live lectures
- 170 questions
- 4 interactive practice exams
- 19 pre-recorded lectures
- Audio and PDF slide-downloads)
Exam answer explanations by expert faculty
TO PURCHASE this course you must login with your ASNC ID and Password. If you do not have an ASNC account, please create one on the ASNC website. Then return to this site to login and purchase the course. You may then start the course.
To ACCESS this course you have already purchased if you have not yet created an ASNC account, please create one on the ASNC website. Use the email address you provided when you purchased the course. Then login with your ASNC User ID and Password, select the My Courses icon on the left vertical dashboard, and select the course to begin.
If you have an ASNC account but have not yet accessed this course, please log in and select the My Courses icon on the left vertical dashboard to begin.
Final Program and Agenda
ASNC Clinical Guidelines and Quality Standards
Method of Participation: CME Credit and Evaluation
Partial CME credit, MOC points and certificates are available for each session. You must listen to the recorded lectures, take the practice exam(s) or post test, and complete the brief evaluation for that session.
For questions related to content or CME credit, please contact ASNC at 703-459-2555 or via email at info@asnc.org. For technical support claiming CME or downloading materials, please contact info@asnc.org.
Target Audience
This course is designed for cardiologists, nuclear medicine physicians, and radiologists preparing for the certification or recertification exam in nuclear cardiology.
Learner Objectives
The primary objectives of the course are to enable participants to achieve the following:
- Apply nuclear cardiovascular imaging physics and instrumentation
- Explain image acquisition and processing considerations and identify associated artifacts
- Discuss the production and management of radionuclides and radiopharmaceuticals
- Incorporate patient-centered imaging principles and appropriate use considerations in nuclear cardiology and stress procedure selection
- Incorporate risk stratification into selection and application of nuclear cardiology studies
- Integrate radiation safety standards into professional nuclear cardiology practice
- Apply nuclear imaging tools in assessment of myocardial viability and cardiac amyloidosis
- Understand the basics of positron emission tomography (PET) imaging for myocardial perfusion and metabolic viability and sarcoidosis assessment
- Interpret SPECT and PET perfusion and metabolic images and ventricular function imaging
- Utilize myocardial perfusion imaging in the assessment, diagnosis, and response to therapy in patients with known or suspected coronary artery disease and special populations
- Appropriately identify non-cardiac findings on SPECT and PET-CT cardiovascular imaging studies
- Integrate nuclear cardiology into the multimodality imaging evaluation of cardiovascular disease
Overall Goal
The overall goal of this activity is to increase physician competence in nuclear cardiology by providing a comprehensive review, including the most up-to-date information, developments, treatment protocols, methodology, and best test for the right patient at the right time to optimize patient outcomes in their nuclear cardiology practice.
Statement of Need
Radionuclide-based cardiac imaging studies, including myocardial perfusion imaging (MPI), play an important role in the diagnosis and management of patients with suspected or known heart disease. Today more than 5000 laboratories are performing an estimated 8 million myocardial perfusion studies, of which 58% use pharmacological stress agents, either alone or with exercise.* A large body of scientific evidence exists on the clinical value of MPI, based on studies performed on many thousands of patients. These studies are highly sensitive and specific for the diagnosis, prognosis, and treatment response of coronary artery disease, as well as for selection of patients who may benefit from other types of intervention, including revascularization and device therapy. The value and justification of MPI for risk assessment is based on large observational outcome studies. As a result of the recognized clinical value and cost effectiveness of these studies, they have been incorporated into many ACC/American Heart Association (AHA)/ASNC clinical management guidelines.
Nuclear cardiology is an evolving field with continuing advances in software, instrumentation, and radiopharmaceuticals to provide high quality, clinically relevant information for patient care. These advances require those involved in providing nuclear cardiology studies to be updated continuously, to ensure the procedures are used appropriately and safely, and to assure recent clinical and technological advances are incorporated in a timely manner to continually improve the image quality and interpretation to provide the best clinical care.
*Dicardiology.com. IMV market report. Posted December 26, 2013.
Accreditation and Continuing Education Credit
Evaluation Deadlines: AMA PRA Category 1 Credits™ and Participation Credits is December 31, 2025.
The American Society of Nuclear Cardiology designates this Other (Internet live with pre-recorded sessions) activity for a maximum of 29.25* AMA PRA Category 1 CreditsTM. Physicians should claim only the credit commensurate with the extent of their participation in the activity.
Requirements for successful completion and awarding of credit are as follows participation in sessions offering credit in their entirety and successful completion of the post-test and evaluation tool.
Maintenance of Certification
Successful completion of this CME activity, which includes participation in the evaluation component, enables the participant to earn up to 29.25* medical knowledge Maintenance of Certification (MOC) points in the American Board of Internal Medicine (ABIM) MOC program. Participants will earn MOC points equivalent to the amount of CME credits claimed for the activity. It is the CME activity provider’s responsibility to submit participant completion information to ACCME for the purpose of granting ABIM MOC points. Physicians should only claim credit commensurate with the extent of their participation in the activity.
To receive MOC points for participating in the Board Prep Course, you must be a diplomate of the American Board of Internal Medicine, and you must have an ABIM account. If you have not established an online account, visit www.abim.org, or contact ABIM by phone: 1-800-441-ABIM; Mon–Fri 8:30 am–8:00 pm ET, Sat 9:00 am–12:00 pm ET.
Please note, upon satisfactory completion of your Board Prep Course, passing the CME post-test and completing the evaluation form, you will be prompted to enter your ABIM ID and date of birth (month/day) to transfer your MOC points to the ABIM. Please allow 5 business days for your ABIM data to be entered into your ABIM record. ABIM will not accept MOC points for this internet live activity after December 31, 2025.
*Credits subject to change
Disclosure Policy and Disclosures
As an accredited provider of the Accreditation Council for Continuing Medical Education (ACCME), The American Society of Nuclear Cardiology (ASNC) adheres to the ACCME’s Standards for Integrity and Independence in Accredited Continuing Education. In compliance with these standards, it is ASNC’s policy to ensure balance, independence, objectivity, and scientific merit in its educational activities through the disclosure of all financial relationship with ineligible companies and mitigation of conflicts of interest. The financial interest or relationships requiring disclosure are outlined in ASNC’s CME Conflict of Interest Policy. All planners, reviewers, and presenters involved with this activity were required to disclose all financial relationships. The American Society of Nuclear Cardiology has reviewed these disclosures and mitigated or managed all identified conflicts of interest through a peer review process.
The following course directors, planners, presenters, reviewers, and staff reported no financial relationships:
Niti R. Aggarwal, MD, FASNC
Marianna Dakanali, PhD
E. Gordon DePuey, MD, MASNC
Rami Doukky, MD, MSc, MBA, FASNC
Dawn Edgerton (ASNC staff)
Simran Grewal, DO
Matthew E. Harinstein, MD
Maria L. Mackin, CNMT, RT(N), FASNC
Wendy Passerell (ASNC staff)
Ronald G. Schwartz, MD, MS, FACC, FAHA, ABNM, MASNC
Anam Waheed, MD
David E. Winchester, MD, MS, FACP, FACC, FASNC
The following planners, presenters, peer reviewers, and staff reported financial relationships:
Karthik Ananthasubramaniam, MD, FASNC: Research grants: Alynylam Pharmaceuticals, Bristol Myers Squibb, Ionis Pharmaceuticals; Speakers Bureau: Bristol Myers Squibb
Benjamin Auer, PhD: Consultant fee: Spectrum Dynamics Medical
Victoria Anderson (ASNC staff): Stock Interest: Abbott, AbbVie Inc.
Jamieson Bourque, MD, MHS, FASNC: Advisory Board: GE Healthcare
James A. Case, PhD, MASNC: Consultant fee: General Electric; Research Grants: Bracco Diagnostics; General Electric, Spectrum Dynamics; Intellectual Property Rights: Cardiovascular Imaging Technologies; Salaried Employee or Owner: Cardiovascular Imaging Technologies
Panithaya Chareonthaitawee, MD, FACC, FAHA: Consultant fee: Clario, Ionetix; Speakers Bureau: Ionetix; Royalties: UpToDate®
C. David Cooke, MSEE: Royalty: Syntermed, Inc. (Sales of Emory Cardiac Toolbox Software); Salaried Employee or Owner: Part-time employee of Syntermed, Inc.
Sanjay Divakaran, MD, MPH: Consultant fee: Kinevant Sciences
Mark C. Hyun, CNMT, NCT, RT(N)(R)(CT), FASNC: Consultant fee: Astellas
Saurabh Malhotra, MD, MPH, FACC, FASNC: Advisory Board: Alnylam, Pfizer; Consultant fees: Viz.ai; Speakers Bureau: Alnylam, AstraZeneca, Pfizer
Prem Soman, MD, PhD, MASNC, FACC, FRCP (UK): Consultant fees: Alnylam, Eidos, Pfizer, Spectrum Dynamics; Research Grants: Pfizer Inc.
Important Dates
Date of Release: August 8, 2024
Date of CME/MOC Claims Expiration: December 31, 2025*
Date of Activity Access Expiration: September 15, 2026
*Please note that credit will only be available through the term of approval noted above.
Acknowledgement of Commercial Support
This activity has no commercial support.
Contact Information
American Society of Nuclear Cardiology
10300 Eaton Place, Suite 301
Fairfax, VA 22030
703-459-2555 | info@asnc.org | www.ASNC.org